N/A
Completed N=37
The Effect of Korean Version of PEERS Social Skills Training for Young Adults (PEERS-YA-K) With Autism Spectrum Disorder
Source: ClinicalTrials.gov NCT03310775 ↗Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcomePrimary: Change From Baseline in Autism Diagnostic Observation Schedule(ADOS) at 4 Month — 3.3; 3.6; 7.5; 8.8 score on a scale
Summary
Despite the psychosocial difficulties common among young adults with autism spectrum disorders(ASD), little to no evidence-based social skills interventions exist for this population. Using a randomized controlled trial(RCT) design, the current study tested the effectiveness of an evidence-based, caregiver-assisted social skills intervention known as PEERS for Young Adults with high-functioning young adults with ASD using self- and caregiver-report measures.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Autism Diagnostic Observation Schedule(ADOS) at 4 Month |
3.3; 3.6; 7.5; 8.8; 1.0; 1.1 | — |
| PRIMARY Change From Baseline in Test of Young Adult Social Skills Knowledge(TYASSK) at 4 Month |
17.5; 21.7 | — |
| PRIMARY Change From Baseline in Korean Version of the Social Skills Rating System (K-SSRS) at 4 Month |
115.7; 108.4 | — |
| PRIMARY Change From Baseline in Social Responsiveness Scale-2 (SRS-2) at 4 Month |
146.5; 147.9 | — |
| SECONDARY Korean Version of the Vineland Adaptive Behavior Scale, Second Edition |
75.0; 70.5; 78.3; 74.4; 71.9; 65.9 | — |
| SECONDARY Change From Baseline in Beck Depression Inventory (BDI) at 4month |
12.8; 14.5 | — |
Eligibility Criteria
Inclusion Criteria
- 18~35 years of age with ASD and IQ of 70 or over
Exclusion Criteria
- Young adults who are hard to understand the content of treatment and carry out the task due to their IQs or limited linguistic abilities
- Young adults who are uncooperative in the treatment, lack motives and are hard to participate voluntarily
- Young adults who have behavior problems so clinically significant that they affects the therapeutic procedure or problems in controlling their emotion and have psychotic symptoms
Data sourced from ClinicalTrials.gov (NCT03310775). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.